Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA for Depression and Slowing in Older Adults
NCT02744391Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in major depressive disorder (MDD), persistent depressive disorder (PDD), depressive disorder not otherwise specified (DD-NOS), sponsored by New York State Psychiatric Institute. Started Aug 2016; status: completed.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)depressive disorder not otherwise specified (DD-NOS)
Beyond the preview
Go deeper on NCT02744391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744391.